Article citationsMore>>

Vogt, A. and Parhofer, K.G. (2013) The Potential of Mipomersen, an ApoB Synthesis Inhibitor, to Reduce Necessity for LDL-Apheresis in Patients with Heterozygous Familial Hypercholesterolemia and Coronary Artery Disease. Expert Opinion on Pharmacotherapy, 14, 691-697.
http://dx.doi.org/10.1517/14656566.2013.779253

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top